Hypertension Diagnostics (HDII) Financial Statements
Hypertension Diagnostics Financial Overview
Hypertension Diagnostics's market cap is currently $285. The company's EPS TTM is $0.00; its P/E ratio is -0.25; Hypertension Diagnostics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 21 | Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 3.79M | $ 3.68M |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 954.47K | $ 752.39K |
| Operating Income | $ -121.89K | $ -11.00K | $ -420.00K | $ -161.00K | $ -403.00K |
| EBITDA | $ 135.24K | $ 225.56K | $ 3.50M | $ 72.29K | $ -179.00K |
| Net Income | $ -93.25K | $ -11.00K | $ 3.29M | $ -125.00K | $ -369.00K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 0.00 | $ 86.39K | $ 86.39K | $ 86.39K | $ 285.43K |
| Total Assets | $ 0.00 | $ 1.08M | $ 1.08M | $ 1.28M | $ 1.49M |
| Total Debt | $ 0.00 | $ 651.32K | $ 775.00K | $ 4.69M | $ 4.42M |
| Net Debt | $ 0.00 | $ 564.93K | $ 688.61K | $ 4.60M | $ 4.13M |
| Total Liabilities | $ 121.89K | $ 2.00M | $ 2.12M | $ 6.03M | $ 6.12M |
| Stockholders' Equity | $ -121.89K | $ -913.71K | $ -1.04M | $ -4.75M | $ -4.63M |
| Cash Flow | |||||
| Free Cash Flow | $ -892.26K | $ -11.00K | $ 3.49M | $ -391.39K | $ -87.95K |
| Operating Cash Flow | $ -892.26K | $ -11.00K | $ 3.49M | $ -389.28K | $ -85.92K |
| Investing Cash Flow | $ 572.13K | $ 0.00 | $ 0.00 | $ -2.11K | $ -2.03K |
| Financing Cash Flow | $ 233.74K | $ 11.00K | $ -3.49M | $ 189.35K | $ 183.19K |
Currency in USD